179 related articles for article (PubMed ID: 3040644)
1. Differential antigen presentation by heat-treated peripheral blood mononuclear cells and Epstein-Barr virus-transformed lymphoblastoid cell lines (EBV-LCL): heated EBV-LCL present alloantigen and soluble antigen but are deficient in the stimulation of autologous EBV-LCL primed T cells.
Mandell RB; Hank JA; Chen BP; Robins HI; Sondel PM
Hum Immunol; 1987 Jul; 19(3):163-77. PubMed ID: 3040644
[TBL] [Abstract][Full Text] [Related]
2. Presentation of soluble antigen to human T cells by products of multiple HLA-linked loci: analysis of antigen presentation by a panel of cloned, autologous, HLA-mutant Epstein-Barr virus-transformed lymphoblastoid cell lines.
Chen BP; DeMars R; Sondel PM
Hum Immunol; 1987 Jan; 18(1):75-91. PubMed ID: 3542914
[TBL] [Abstract][Full Text] [Related]
3. Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines.
Reitnauer PJ; Brown LR; Hank JA; Sondel PM
Cell Immunol; 1986 Apr; 99(1):196-208. PubMed ID: 3019572
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
Wasik M; Matej H; Duś D; Myc A
Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
[TBL] [Abstract][Full Text] [Related]
5. The proliferative immune response to autologous Epstein-Barr virus-transformed lymphoblastoid cells. I. Studies with HLA haplotype loss variants demonstrate a role for MHC-linked genes.
Reitnauer PJ; DeMars R; Sondel PM
Hum Immunol; 1985 Jul; 13(3):177-91. PubMed ID: 2989227
[TBL] [Abstract][Full Text] [Related]
6. MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways.
Lee SP; Wallace LE; Mackett M; Arrand JR; Searle PF; Rowe M; Rickinson AB
Int Immunol; 1993 May; 5(5):451-60. PubMed ID: 8391306
[TBL] [Abstract][Full Text] [Related]
7. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
[TBL] [Abstract][Full Text] [Related]
8. Alloantigen-induced enhancement and suppression of human cytotoxic lymphocyte responses to autologous lymphoblastoid cell lines.
Zarling JM; Bach FH
Scand J Immunol; 1978; 8(5):377-85. PubMed ID: 152971
[TBL] [Abstract][Full Text] [Related]
9. Accessory signals in T-T cell interactions between antigen- and alloantigen-specific, human memory T cells generated in vitro.
Odum N; Ryder LP; Georgsen J; Jakobsen BK; Geisler C; Møller J; Morling N; Dickmeiss E; Svejgaard A
Scand J Immunol; 1990 Jun; 31(6):717-28. PubMed ID: 2162555
[TBL] [Abstract][Full Text] [Related]
10. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
Hank JA; Sondel PM
Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468
[TBL] [Abstract][Full Text] [Related]
11. Use of Epstein-Barr virus-transformed, autologous B-lymphoblastoid cells as antigen-presenting cells for establishment and maintenance of dengue virus-specific, human cytotoxic T lymphocyte clones.
Livingston PG; Kurane I; Ennis FA
J Virol Methods; 1997 Aug; 67(1):77-84. PubMed ID: 9274820
[TBL] [Abstract][Full Text] [Related]
12. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
13. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
Tanaka Y; Sugamura K; Hinuma Y
J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
[TBL] [Abstract][Full Text] [Related]
15. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
Chen BP; DeMars R; Hank JA; Sondel PM
Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068
[TBL] [Abstract][Full Text] [Related]
16. Establishment of human cytotoxic T-cell lines specific for Epstein-Barr virus-transformed autologous cells.
Sugamura K; Tanaka Y; Hinuma Y
Int J Cancer; 1981 Aug; 28(2):137-42. PubMed ID: 6274810
[TBL] [Abstract][Full Text] [Related]
17. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
Torsteinsdottir S; Masucci MG; Brautbar C; Lenoir G; Klein G; Klein E
Cell Immunol; 1986 Apr; 98(2):453-66. PubMed ID: 3019570
[TBL] [Abstract][Full Text] [Related]
18. EBV-B cells as antigen presenting cells in characterization of the self/donor context of allorecognition by T lymphocytes.
Drouet C; Arvieux C; Devouassoux G; Csopaki F; Chavanon O; Brichon PY; Letoublon C; Zarski JP; Barnoud D; Pison C
Transpl Immunol; 1998 Dec; 6(4):209-15. PubMed ID: 10342734
[TBL] [Abstract][Full Text] [Related]
19. CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens.
Mutis T; Schrama E; Melief CJ; Goulmy E
Blood; 1998 Sep; 92(5):1677-84. PubMed ID: 9716596
[TBL] [Abstract][Full Text] [Related]
20. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
